Efficacy, safety, and cost-effectiveness of reduced-dose olanzapine versus aprepitant as a part of triple-antiemetic therapy in the prevention of chemotherapy-induced nausea and vomiting - Mohammed, O; Thota, N K (J Clin Oncol, 2022)